UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Dexamethasone in hyperleukocytic acute myeloid leukemia

Haematologica (Roma), 2018-06, Vol.103 (6), p.988-998

2018

Volltextzugriff (PDF)

Somatic genetic alterations predict hematological progression in GATA2 deficiency

Haematologica (Roma), 2023-06, Vol.108 (6), p.1515-1529

2023

Volltextzugriff (PDF)

Genomic landscape of hyperleukocytic acute myeloid leukemia

Blood cancer journal (New York), 2022-01, Vol.12 (1), p.4-4, Article 4

2022

Volltextzugriff (PDF)

Poor prognosis of chromosome 7 clonal aberrations in Philadelphia-negative metaphases and relevance of potential underlying myelodysplastic features in chronic myeloid leukemia

Haematologica (Roma), 2019-06, Vol.104 (6), p.1150-1155

2019

Volltextzugriff (PDF)

Intermediate-dose cytarabine or standard-dose cytarabine plus single-dose anthracycline as post-remission therapy in older patients with acute myeloid leukemia: impact on health care resource consumption and outcomes

Blood cancer journal (New York), 2021-11, Vol.11 (11), p.180-180, Article 180

2021

Volltextzugriff (PDF)

Impact of obesity in favorable‐risk AML patients receiving intensive chemotherapy

American journal of hematology, 2016-02, Vol.91 (2), p.193-198

2016

Volltextzugriff (PDF)

Addition of Lomustine to Idarubicin and Cytarabine Improves the Outcome of Elderly Patients With De Novo Acute Myeloid Leukemia: A Report From the GOELAMS

Journal of clinical oncology, 2010-06, Vol.28 (18), p.3028-3034

2010

Volltextzugriff (PDF)

The peculiar 11q-gain/loss aberration reported in a subset of MYC -negative high-grade B-cell lymphomas can also occur in a MYC -rearranged lymphoma

Cancer genetics, 2016-03, Vol.209 (3), p.117-118

2016

Volltextzugriff (PDF)

Place de la cytogénétique dans le diagnostic des leucémies aiguës myéloïdes

Revue francophone des laboratoires, 2015-04, Vol.2015 (471), p.43-49

Luquet, Isabelle

2015

Volltextzugriff (PDF)

Tyrosine Kinase Inhibitors with Intensive Chemotherapy in AML with t(9;22)(q34.1;q11.2)/ BCR::ABL1 : Time to Reconsider Prognostic Risk? a Study from the Dataml Registry

Blood, 2023-11, Vol.142 (Supplement 1), p.1473-1473

2023

Volltextzugriff (PDF)

Cytogenetics in the management of acute myeloid leukemia and histiocytic/dendritic cell neoplasms: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH)

Current research in translational medicine, 2023-10, Vol.71 (4)

2023

Volltextzugriff (PDF)

Cytogenetics in the management of acute myeloid leukemia and histiocytic/dendritic cell neoplasms: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH)

Current research in translational medicine, 2023-10, Vol.71 (4), p.103421-103421, Article 103421

2023

Volltextzugriff (PDF)

Cytogenetics in the management of B-cell acute lymphoblastic leukemia: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH)

Current research in translational medicine, 2023-10, Vol.71 (4), p.103434-103434, Article 103434

2023

Volltextzugriff (PDF)

Cytogenetics in the management of T-cell acute lymphoblastic leukemia (T-ALL): Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH)

Current research in translational medicine, 2023-10, Vol.71 (4), p.103431-103431, Article 103431

2023

Volltextzugriff (PDF)

Prognostic Impact of Unsupervised Early Assessment of Bulk and Leukemic Stem Cell Measurable Residual Disease in Acute Myeloid Leukemia

Clinical cancer research, 2023-01, Vol.29 (1), p.134-142

2023

Volltextzugriff (PDF)

The presence of a chromosomal abnormality in cytopenia without dysplasia identifies a category of high‐risk clonal cytopenia of unknown significance

Genes chromosomes & cancer, 2023-03, Vol.62 (3), p.139-151

2023

Volltextzugriff (PDF)

7q22 deletion in myeloid malignancies: be attentive to the design of the FISH probe

Annales de biologie clinique (Paris), 2019-04, Vol.77 (2), p.229-230

2019

Volltextzugriff (PDF)

Optimizing the Supportive Care of Intensive Chemotherapy in AML : Impact of Vitamin C and D Supplementation in Patients with NPM1 Mutation. a Dataml Registry Study

Blood, 2022-11, Vol.140 (Supplement 1), p.3239-3241

2022

Volltextzugriff (PDF)

Artificial Intelligence-Based Predictive Models for Acute Myeloid Leukemia

Blood, 2021-11, Vol.138 (Supplement 1), p.3389-3389

2021

Volltextzugriff (PDF)

Genomics of Hyperleukocytic Acute Myeloid Leukemia

Blood, 2021-11, Vol.138 (Supplement 1), p.1294-1294

2021

Volltextzugriff (PDF)

Current Results of Intensive Therapy in Younger Adults with Acute Myeloid Leukemia (AML): The Large Randomized French Backbone Intergroup (BIG)-1 Study on Behalf of the Filo, ALFA, and SFGM-TC Study Groups

Blood, 2023-11, Vol.142 (Supplement 1), p.967-967

2023

Volltextzugriff (PDF)

1 – 25 von 128

Suche als RSS-Feed

Aktive Filter

ThemaLeukemia

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(116)
Mit Volltextzugriff
(109)

Publikationsform

Sprache

Englisch
(122)
Französisch
(7)

Erscheinungsjahr

n.n

Thema

Science & Technology
(65)
Life Sciences & Biomedicine
(61)
Humans
(50)
Hematology
(38)
Life Sciences
(36)
Male
(32)
Female
(29)
Middle Aged
(27)
Oncology
(24)
Adult
(18)
Aged
(16)
Leukemia, Myeloid, Acute - Drug Therapy
(13)
Leukemia, Myeloid, Acute - Genetics
(13)
Prognosis
(13)
Chromosome Aberrations
(12)
Animals
(11)
Mutation
(10)
Cancer
(9)
Retrospective Studies
(9)
Adolescent
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(38)
Leukemia & Lymphoma
(8)
Annales De Biologie Clinique
(7)
Blood Advances
(5)
Haematologica
(5)
Current Research In Translational Medicine
(4)
Blood Cancer Journal
(3)
European Journal Of Haematology
(3)
Leukemia Research
(3)
Plos One
(3)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Dexamethasone in hyperleukocytic acute myeloid leukemia

Somatic genetic alterations predict hematological progression in GATA2 deficiency

Genomic landscape of hyperleukocytic acute myeloid leukemia

Poor prognosis of chromosome 7 clonal aberrations in Philadelphia-negative metaphases and relevance of potential underlying myelodysplastic features in chronic myeloid leukemia

Chromosomal aberrations and their prognostic value in a series of 174 untreated patients with Waldenström's macroglobulinemia

Intermediate-dose cytarabine or standard-dose cytarabine plus single-dose anthracycline as post-remission therapy in older patients with acute myeloid leukemia: impact on health care resource consumption and outcomes

Wide diversity of PAX5 alterations in B-ALL: a Groupe Francophone de Cytogénétique Hématologique study

Impact of obesity in favorable‐risk AML patients receiving intensive chemotherapy

Prognostic impact of day 15 blast clearance in risk-adapted remission induction chemotherapy for younger patients with acute myeloid leukemia: long-term results of the multicenter prospective LAM-2001 trial by the GOELAMS study group

Addition of Lomustine to Idarubicin and Cytarabine Improves the Outcome of Elderly Patients With De Novo Acute Myeloid Leukemia: A Report From the GOELAMS

The peculiar 11q-gain/loss aberration reported in a subset of MYC -negative high-grade B-cell lymphomas can also occur in a MYC -rearranged lymphoma

Place de la cytogénétique dans le diagnostic des leucémies aiguës myéloïdes

Prospective evaluation of gene mutations and minimal residual disease in patients with core binding factor acute myeloid leukemia

Tyrosine Kinase Inhibitors with Intensive Chemotherapy in AML with t(9;22)(q34.1;q11.2)/ BCR::ABL1 : Time to Reconsider Prognostic Risk? a Study from the Dataml Registry

Cytogenetics in the management of acute myeloid leukemia and histiocytic/dendritic cell neoplasms: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH)

Cytogenetics in the management of acute myeloid leukemia and histiocytic/dendritic cell neoplasms: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH)

Cytogenetics in the management of B-cell acute lymphoblastic leukemia: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH)

Cytogenetics in the management of T-cell acute lymphoblastic leukemia (T-ALL): Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH)

Prognostic Impact of Unsupervised Early Assessment of Bulk and Leukemic Stem Cell Measurable Residual Disease in Acute Myeloid Leukemia

The presence of a chromosomal abnormality in cytopenia without dysplasia identifies a category of high‐risk clonal cytopenia of unknown significance

7q22 deletion in myeloid malignancies: be attentive to the design of the FISH probe

Optimizing the Supportive Care of Intensive Chemotherapy in AML : Impact of Vitamin C and D Supplementation in Patients with NPM1 Mutation. a Dataml Registry Study

Artificial Intelligence-Based Predictive Models for Acute Myeloid Leukemia

Genomics of Hyperleukocytic Acute Myeloid Leukemia

Current Results of Intensive Therapy in Younger Adults with Acute Myeloid Leukemia (AML): The Large Randomized French Backbone Intergroup (BIG)-1 Study on Behalf of the Filo, ALFA, and SFGM-TC Study Groups

Aktive Filter

Suchergebnisse filtern